214 related articles for article (PubMed ID: 31939065)
1. Targeting the menaquinol binding loop of mycobacterial cytochrome bd oxidase.
Harikishore A; Chong SSM; Ragunathan P; Bates RW; Grüber G
Mol Divers; 2021 Feb; 25(1):517-524. PubMed ID: 31939065
[TBL] [Abstract][Full Text] [Related]
2. Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?
Bajeli S; Baid N; Kaur M; Pawar GP; Chaudhari VD; Kumar A
Front Cell Infect Microbiol; 2020; 10():589318. PubMed ID: 33330134
[TBL] [Abstract][Full Text] [Related]
3. Exploiting the synthetic lethality between terminal respiratory oxidases to kill
Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330
[TBL] [Abstract][Full Text] [Related]
4. Features and Functional Importance of Key Residues of the
Sviriaeva E; Subramanian Manimekalai MS; Grüber G; Pethe K
ACS Infect Dis; 2020 Jul; 6(7):1697-1707. PubMed ID: 32379966
[TBL] [Abstract][Full Text] [Related]
5. Cryo-Electron Microscopy Structure of the
Mathiyazakan V; Wong CF; Harikishore A; Pethe K; Grüber G
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0153122. PubMed ID: 37158740
[TBL] [Abstract][Full Text] [Related]
6. Targeting the cytochrome oxidases for drug development in mycobacteria.
Lee BS; Sviriaeva E; Pethe K
Prog Biophys Mol Biol; 2020 May; 152():45-54. PubMed ID: 32081616
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome
Fischer M; Falke D; Naujoks C; Sawers RG
J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29784883
[No Abstract] [Full Text] [Related]
8. Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy.
Zhou Y; Shao M; Wang W; Cheung CY; Wu Y; Yu H; Hu X; Cook GM; Gong H; Lu X
Eur J Med Chem; 2023 Jan; 245(Pt 1):114896. PubMed ID: 36370551
[TBL] [Abstract][Full Text] [Related]
9. Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis.
Lee BS; Hards K; Engelhart CA; Hasenoehrl EJ; Kalia NP; Mackenzie JS; Sviriaeva E; Chong SMS; Manimekalai MSS; Koh VH; Chan J; Xu J; Alonso S; Miller MJ; Steyn AJC; Grüber G; Schnappinger D; Berney M; Cook GM; Moraski GC; Pethe K
EMBO Mol Med; 2021 Jan; 13(1):e13207. PubMed ID: 33283973
[TBL] [Abstract][Full Text] [Related]
10. Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria.
Cook GM; Hards K; Vilchèze C; Hartman T; Berney M
Microbiol Spectr; 2014 Jun; 2(3):. PubMed ID: 25346874
[TBL] [Abstract][Full Text] [Related]
11. Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa3.
Kim MS; Jang J; Ab Rahman NB; Pethe K; Berry EA; Huang LS
J Biol Chem; 2015 Jun; 290(23):14350-60. PubMed ID: 25861988
[TBL] [Abstract][Full Text] [Related]
12. The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress.
Lu P; Heineke MH; Koul A; Andries K; Cook GM; Lill H; van Spanning R; Bald D
Sci Rep; 2015 May; 5():10333. PubMed ID: 26015371
[TBL] [Abstract][Full Text] [Related]
13. Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption.
Matsoso LG; Kana BD; Crellin PK; Lea-Smith DJ; Pelosi A; Powell D; Dawes SS; Rubin H; Coppel RL; Mizrahi V
J Bacteriol; 2005 Sep; 187(18):6300-8. PubMed ID: 16159762
[TBL] [Abstract][Full Text] [Related]
14. Novel targets and inhibitors of the
Harikishore A; Mathiyazakan V; Pethe K; Grüber G
Expert Opin Drug Discov; 2023; 18(8):917-927. PubMed ID: 37332221
[TBL] [Abstract][Full Text] [Related]
15. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc
Kalia NP; Shi Lee B; Ab Rahman NB; Moraski GC; Miller MJ; Pethe K
Sci Rep; 2019 Jun; 9(1):8608. PubMed ID: 31197236
[TBL] [Abstract][Full Text] [Related]
16. Antituberculosis Activity of the Antimalaria Cytochrome
Chong SMS; Manimekalai MSS; Sarathy JP; Williams ZC; Harold LK; Cook GM; Dick T; Pethe K; Bates RW; Grüber G
ACS Infect Dis; 2020 Apr; 6(4):725-737. PubMed ID: 32092260
[TBL] [Abstract][Full Text] [Related]
17. Menaquinol oxidase activity and primary structure of cytochrome bd from the amino-acid fermenting bacterium Corynebacterium glutamicum.
Kusumoto K; Sakiyama M; Sakamoto J; Noguchi S; Sone N
Arch Microbiol; 2000; 173(5-6):390-7. PubMed ID: 10896219
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome bc1-aa3 Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis.
Sindhu T; Debnath P
Curr Mol Pharmacol; 2022; 15(2):380-392. PubMed ID: 34602044
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Mycobacterium tuberculosis Cytochrome
Moosa A; Lamprecht DA; Arora K; Barry CE; Boshoff HIM; Ioerger TR; Steyn AJC; Mizrahi V; Warner DF
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760899
[TBL] [Abstract][Full Text] [Related]
20. Nitric Oxide Does Not Inhibit but Is Metabolized by the Cytochrome
Forte E; Giuffrè A; Huang LS; Berry EA; Borisov VB
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
